An interventional study of Education Support in Stress, Psychological and Adaptation, Psychological, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by University of Michigan · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 290 studies in Stress, Psychological with a site in United States — 31 open to participants now, 46 under way, 1 of them phase 3. Stress, Psychological · United States.
Among the 290 studies in Stress, Psychological with a site in United States, this one is the 228th largest by enrollment of the 262 interventional ones that give a count, is one of 12 that started in 2025, is one of 240 with no phase, and was the 185th registered.
854 studies on the registry are indexed under Stress, Psychological; 141 are open to participants now.
Browse Stress, Psychological studies →31 of the 290 studies in Stress, Psychological with a site in United States are open now. Recruiting first, the newest first:
Rachel Yehuda · Sites in United States
Ages 18+
University of Pennsylvania · Sites in United States
Ages 21–60 · Healthy volunteers
University of Florida · Sites in United States
Ages 30–55 · Healthy volunteers
University of Arizona · Sites in United States
Ages 65+ · Healthy volunteers
Efforia, Inc · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 74 Stress, Psychological studies recruiting now, 34 (46%) set no upper age limit and 36 (49%) stop at 75 or younger; 13 take children under 18; 49 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
290 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 11 · Phase 3 3 · Phase 4 3
First in 1997; this study’s year is marked. 12 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 25 is below the median of 84 across 698 interventional studies indexed under Stress, Psychological.
Median enrollment 84 across the 262 interventional studies, 138 across the 28 observational. Of the 226 that completed or were terminated, 60 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 290 have an industry lead sponsor. The 10 most frequent:
University of Michigan is the lead sponsor of 1,509 studies on the registry; 194 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 134 (79%) have results posted.
University of Michigan has 4 studies filed under Stress, Psychological — fewer than ten, so there is no comparison to draw.
19 of the studies in Stress, Psychological with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05552053Phase 3Cedars-Sinai Medical CenterResources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women | 2026-12-31 |
| NCT07718646Oklahoma State UniversityMobile Health Coping Intervention for Mothers Experiencing Food Insecurity | 2026-11 |
| NCT06989593Sarah SchlegelBreaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions | 2026-11 |
| NCT04317482University of ArkansasThe Human Stress Response in a Simulated ED Setting | 2026-12 |
| NCT07029165University of Massachusetts, BostonKidney Blood Flow During Exercise in Older African American Adults | 2026-12 |
Add all 19 to your calendar (.ics) → With an account.
Among the 290 studies in Stress, Psychological with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Black family caregivers of older adults with Alzheimer's disease and/or related dementias (ADRD), have an increased mortality risk related to pre-existing health conditions and stress. Targeted, culturally responsive, health interventions that help Black ADRD caregivers to effectively manage their own health and use community preferenced ways of coping, can improve caregivers' overall health, perceived ability to provide care for a person with ADRD (self-efficacy), and increases the likelihood that they will experience benefits from caregiving. This clinical trial pilot will test the feasibility of a community based intervention designed to improve health outcomes for Black family caregivers of persons with ADRD.
The proposed intervention is a peer-supportive and facilitator-led video teleconference program that will engage small groups of caregivers weekly over 6 weeks. Each week participants (n = 36, 2-5/group) will receive a different culturally relevant caregiving or personal health strategy to practice. During the support calls, a facilitator will provide an overview of the content covered and each participant will have the opportunity to discuss their past week and how they engaged the weekly strategy, or challenges that came up for them during the week. The format will be structured to ensure that core content is reviewed, and everyone can be equally engaged while flexible enough that caregivers can receive support in the areas they need. A battery of assessment measures will be taken at weeks 1 and 8.
Inclusion criteria for participation are as follows:
Self-identified as Black/ African American At least 18 years old Able to speak, understand, and hear spoken English Related to, or has a close personal relationship to a person over the age of 55 that has an ADRD diagnosis or evidence of cognitive impairment Regular access to a smartphone, tablet or computer with internet access that will allow video conferencing engagement.
Provides monitoring, and assistance in activities of daily living and or other care tasks for the care recipient.
-
All participants in all groups will receive 6 weeks of caregiving support including a weekly video/teleconference call, and handouts covering relevant educational topics)
Behavioral: Education Support
Caregivers engage in a weekly video/teleconference support group with a skilled facilitator to discuss various strategies for managing caregiving stress, challenging behaviors, and personal self-care.
Caregiver Self-efficacy for Obtaining Respite Care
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.
Time frame: 6 weeks
Caregiver Self-Efficacy for Controlling Upsetting Thoughts
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.
Time frame: 6 Weeks
Caregiver Self-Efficacy for Responding to Disruptive Behaviors
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.
Time frame: 6 Weeks
Positive Aspects of Caregiving
The Positive Aspects of Caregiving tool is a brief assessment measure that asks questions about caregiving experiences that made the caregiver feel good about providing care. Responses are rated from 1, disagree a lot, to 5, agree a lot. Scores range from 9 to 45 with higher scores indicating more positive experiences related to family caregiving.
Time frame: 6 weeks
Participants were recruited using a study flyer distributed through organizations servicing older adults and persons with dementia in the metro detroit. A Facebook marketing campaign was also completed. Screening surveys were completed by 513 potential participants. Screening and recruitment took place between March 2025 and August 2025.
| Milestone | Caregiver Support |
|---|---|
| Started | 25 |
| Completed | 23 |
| Not completed | 2 |
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.
| percent | Caregiver Support |
|---|---|
| Caregiver Self-efficacy for Obtaining Respite Care | 85.21 (78.12 to 92.31) |
The Positive Aspects of Caregiving tool is a brief assessment measure that asks questions about caregiving experiences that made the caregiver feel good about providing care. Responses are rated from 1, disagree a lot, to 5, agree a lot. Scores range from 9 to 45 with higher scores indicating more positive experiences related to family caregiving.
| points | Caregiver Support |
|---|---|
| Positive Aspects of Caregiving | 33.47 (28.69 to 38.27) |
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.
| Percent | Caregiver Support |
|---|---|
| Caregiver Self-Efficacy for Controlling Upsetting Thoughts | 85.21 (78.12 to 92.31) |
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.
| Percent | Caregiver Support |
|---|---|
| Caregiver Self-Efficacy for Responding to Disruptive Behaviors | 82 (76.36 to 87.64) |
Collected over From enrollment until the end of follow-up, up to 8 weeks. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Caregiver Support | 0/25 (0%) | 0/25 (0%) | 0/25 (0%) |
Complete data is available for 22-23 participants, depending on the measure
| Age, Continuous(years) | Caregiver Support |
|---|---|
| Mean | 54.74 ± 10.79 |
| Sex: Female, Male(Participants) | Caregiver Support |
|---|---|
| Female | 18 |
| Male | 5 |
| Race (NIH/OMB)(Participants) | Caregiver Support |
|---|---|
| American Indian or Alaska Native | 0 |
| Asian | 0 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 23 |
| White | 0 |
| More than one race | 0 |
| Unknown or Not Reported | 0 |
| Caregiver Self-Efficacy(Percentage) | Caregiver Support |
|---|---|
| Self-Efficacy in Obtaining Respite Care | 74.17 ± 35.23 |
| Self-Efficacy in Controlling Obsetting Thoughts | 89.45 ± 98.68 |
| Self-Efficacy in Responding to Disruptive Behavior | 84.35 ± 15.67 |
| Positive Aspects of Caregiving Scale(points) | Caregiver Support |
|---|---|
| Mean | 33.38 ± 10.41 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — It is anticipated that the following data will be generated and made available 1) published tables, figures, graphs, and tables of data used for making graphs; 2) published journal papers, conference papers, annual reports and the final report; and 3) educational materials resulting from intervention development. All data will conform with relevant data and terminology standards.
Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code
Time frame: No less than 5 years following the date of the project completion or the date of study publication.
Access criteria: To facilitate data sharing, project data will be made publicly available via a university-managed repository Deep Blue.
Data sharing details ↗ · deepblue.lib.umich.edu
Ran from Mar 2025 to primary completion in Oct 2025, 7 months.
Results were first posted in Nov 2026, 1 year after primary completion.
Of 462 non-industry interventional studies with no phase under Stress, Psychological, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 7 months is below that.
Counting every sponsor, half of 475 studies reached it within 13 months; a quarter within 5 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.